Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Not Yet Recruiting NCT05707767

A Prospective Study of Surgical Treatment Strategies for Chordoma

Conditions: Chordoma of Spine, Surgery

Sex: All
Ages: 18 Years – 70 Years
Phase: NA
Enrollment: 100
Sponsor: Xuanwu Hospital, Beijing

Summary

Chordoma is a rare but locally invasive cancer that arises from the embryonic notochord. Total resection is challenging in mobile spine because of the complex anatomy and bone invasion.

Eligibility Criteria

Inclusion Criteria:Between the ages of 18 and 70 ys,With a diagnosis of chordoma confirmed by pathology,Undergone surgical treatment in our hospital,Available for clinical follow-up and agree to long-term clinical follow-up and sign informed consent.Exclusion Criteria:Suffer from other tumors,Suffer from cardiovascular disease, cerebrovascular disease, or immune system disease.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05707767). StuddyBuddy aggregates publicly available trial information.